Benchmark Bullish on Semler Scientific: $101 Price Target After Bold Bitcoin Treasury Move
Wall Street wakes up to a medtech firm's crypto gamble.
Semler Scientific just got the ultimate trader's stamp of approval—a buy rating with a side of price target optimism. Benchmark analysts slapped a $101 valuation on the company after its eyebrow-raising pivot to holding Bitcoin as treasury reserve.
Because nothing says '2025 growth strategy' like swapping sterile cash for volatile digital assets. The move echoes MicroStrategy's playbook—though whether that's a compliment depends on which week you check the charts.
One thing's certain: in an era where even stodgy healthcare firms catch crypto fever, the lines between tech and finance keep blurring. Just don't ask your CFA about it.